Viking Therapeutics Stock Price Prediction
VKTX Stock | USD 74.95 0.64 0.86% |
Oversold Vs Overbought
0
Oversold | Overbought |
Viking Therapeutics stock price prediction is an act of determining the future value of Viking Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Viking Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Viking Therapeutics and does not consider all of the tangible or intangible factors available from Viking Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Viking Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Viking Therapeutics' stock price prediction:EPS Estimate Next Quarter (0.28) | EPS Estimate Current Year (1.10) | EPS Estimate Next Year (1.54) | Wall Street Target Price 113.8 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Viking Therapeutics based on different types of headlines from major news networks to social media. The Viking stock price prediction module provides an analysis of price elasticity to changes in media outlook on Viking Therapeutics over a specific investment horizon. Using Viking Therapeutics hype-based prediction, you can estimate the value of Viking Therapeutics from the perspective of Viking Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Viking Therapeutics using Viking Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Viking using crowd psychology based on the activity and movement of Viking Therapeutics' stock price.
Viking Therapeutics Short Interest
A significant increase or decrease in Viking Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Viking. Short interest can provide insight into the potential direction of Viking Therapeutics stock and how bullish or bearish investors feel about the market overall. An investor who is long Viking Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Viking Therapeutics and may potentially protect profits, hedge Viking Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 28.7054 | Short Percent 0.1364 | Short Ratio 2.53 | Shares Short Prior Month 9.5 M | 50 Day MA 68.1096 |
Viking Therapeutics Hype to Price Pattern
Investor biases related to Viking Therapeutics' public news can be used to forecast risks associated with an investment in Viking. The trend in average sentiment can be used to explain how an investor holding Viking can time the market purely based on public headlines and social activities around Viking Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Viking Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Viking Therapeutics.
Viking Therapeutics Implied Volatility | 111.74 |
Viking Therapeutics' implied volatility exposes the market's sentiment of Viking Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Viking Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Viking Therapeutics stock will not fluctuate a lot when Viking Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Viking Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Viking Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Viking because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Viking Therapeutics after-hype prediction price | USD 67.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Viking contract
Based on the Rule 16, the options market is currently suggesting that Viking Therapeutics will have an average daily up or down price movement of about 6.98% per day over the life of the 2024-05-03 option contract. With Viking Therapeutics trading at USD 74.95, that is roughly USD 5.23 . If you think that the market is fully incorporating Viking Therapeutics' daily price movement you should consider acquiring Viking Therapeutics options at the current volatility level of 111.74%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Viking |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viking Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Viking Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Viking Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Viking Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Viking Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Viking Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Viking Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Viking Therapeutics' historical news coverage. Viking Therapeutics' after-hype downside and upside margins for the prediction period are 50.81 and 83.77, respectively. We have considered Viking Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Viking Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Viking Therapeutics is based on 3 months time horizon.
Viking Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Viking Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Viking Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Viking Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.65 | 16.35 | 6.94 | 1.48 | 10 Events / Month | 15 Events / Month | In about 10 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
74.95 | 67.29 | 9.45 |
|
Viking Therapeutics Hype Timeline
Viking Therapeutics is at this time traded for 74.95. The entity has historical hype elasticity of -6.94, and average elasticity to hype of competition of -1.48. Viking is anticipated to decline in value after the next headline, with the price expected to drop to 67.29. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -9.45%, whereas the daily expected return is at this time at 2.65%. The volatility of related hype on Viking Therapeutics is about 2919.64%, with the expected price after the next announcement by competition of 73.47. About 72.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 0.92. Viking Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Viking Therapeutics Basic Forecasting Models to cross-verify your projections.Viking Therapeutics Related Hype Analysis
Having access to credible news sources related to Viking Therapeutics' direct competition is more important than ever and may enhance your ability to predict Viking Therapeutics' future price movements. Getting to know how Viking Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Viking Therapeutics may potentially react to the hype associated with one of its peers.
Viking Therapeutics Additional Predictive Modules
Most predictive techniques to examine Viking price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Viking using various technical indicators. When you analyze Viking charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Viking Therapeutics Predictive Indicators
The successful prediction of Viking Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Viking Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Viking Therapeutics based on analysis of Viking Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Viking Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Viking Therapeutics's related companies. Story Coverage note for Viking Therapeutics
The number of cover stories for Viking Therapeutics depends on current market conditions and Viking Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Viking Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Viking Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Viking Therapeutics Short Properties
Viking Therapeutics' future price predictability will typically decrease when Viking Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Viking Therapeutics often depends not only on the future outlook of the potential Viking Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Viking Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 94.3 M | |
Cash And Short Term Investments | 362.1 M |
Check out Viking Therapeutics Basic Forecasting Models to cross-verify your projections. For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Viking Stock analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Viking Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viking Therapeutics. If investors know Viking will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viking Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Return On Assets (0.13) | Return On Equity (0.18) |
The market value of Viking Therapeutics is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Viking Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Therapeutics' market value can be influenced by many factors that don't directly affect Viking Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viking Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Viking Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.